America’s biopharmaceutical companies have joined forces to fight COVID-19. Armed with experience garnered from previous outbreaks and a vast storehouse of knowledge about infectious diseases like influenza, malaria and HIV, researchers are working to develop and deliver diagnostics, treatments and vaccines to save lives and restore the rhythms of daily life for billions of people.
Below is a new graphic illustrating how America’s biopharmaceutical companies are utilizing diagnostics, existing medicines, new treatments, manufacturing, and vaccines for one shared goal: Fighting COVID-19.
You can also get the latest on the biopharmaceutical industry’s efforts to beat COVID-19 here.
Tom Wilbur Tom Wilbur is director of public affairs at PhRMA focusing on federal advocacy priorities including Medicare and intellectual property. Prior to joining PhRMA, Tom worked in politics and on Capitol Hill, most recently responsible for communications and strategy for U.S. Rep. Fred Upton and the House Energy and Commerce Committee. Tom is a proud Michigander and outside of the office enjoys reading, running, hiking, golfing, live music, and spending time with family and friends.